WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of its management team will take part in a fireside chat at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5th, at 10:30 AM ET.
A live webcast of the panel discussion and fireside chat at the Jefferies Global Healthcare Conference will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.
About Morphic Therapeutic
Morphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Morphic is also advancing its pipeline and discovery activities in collaboration with Schrödinger using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.
Contacts
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…
New findings published in Alzheimer's & Dementia suggest blood biomarkers are expected to become the…
Olympus Will Highlight the Platform at Annual SAGES Meeting CENTER VALLEY, Pa., March 12, 2025…
SAN DIEGO, March 12, 2025 /PRNewswire/ -- AAAAI 2025 was more than just a conference—it…
TEL AVIV, Israel, March 12, 2025 /PRNewswire/ -- Startup Nation Central, in partnership with the…
Montreal, Quebec--(Newsfile Corp. - March 12, 2025) - March 13 is World Kidney Day. Now…